Concepedia

Stefan Faderl

SF

Statistics

Publications

51

Citations

5.3K

H-Index

29

Active since

2000

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Moffitt Cancer Center

University of Kansas Medical Center

Jazz Pharmaceuticals (United States)

Washington University in St. Louis

Stefan Faderl is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and chemotherapy.

Publications per year

2000–2022

51

Publications

51

Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic Leukemia

Michael J. Keating, Susan O’Brien, Maher Albitar et al. · Journal of Clinical Oncology · 2005 · 951 citations · Full text

, , +14

New Comprehensive Cytogenetic Scoring System for Primary Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia After MDS Derived From an International Database Merge

Julie Schanz, Heinz Tüchler, Françesc Solé et al. · Journal of Clinical Oncology · 2012 · 691 citations · Full text

, , +17

Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia

Hagop M. Kantarjian, Yasuhiro Oki, Guillermo Garcia‐Manero et al. · Blood · 2006 · 689 citations · Full text

, , +16

Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia

Alessandra Ferrajoli, Bang-Ning Lee, Ellen Schlette et al. · Blood · 2008 · 398 citations · Full text

, , +11

Epigenetic therapy is associated with similar survival compared with intensive chemotherapy in older patients with newly diagnosed acute myeloid leukemia

Alfonso Quintás‐Cardama, Farhad Ravandi, Theresa Liu-Dumlao et al. · Blood · 2012 · 219 citations · Full text

, , +13

1–5 of 51